Chris Peterson is a Director in the Emerging Therapeutics department at Express Scripts. He is responsible for monitoring and analyzing the pharmaceutical market, including the traditional drug pipeline and patent expirations. In his role, Chris contributes to timely communications on various clinical topics, including new drug approvals, generic drug approvals, new guidelines and landmark-study publications. Dr. Peterson also contributes to Express Scripts’ Drug Trend Report. The Emerging Therapeutics department produces several proprietary reports on the pipeline and patent landscape for use by Express Scripts’ employees and clients. The Emerging Therapeutics department is also responsible for the safety program that alerts patients, physicians and clients to important information regarding serious drug safety alerts and market withdrawals.
Dr. Peterson has spent 16 years in the pharmacy-benefit-management industry. He received his Doctor of Pharmacy degree from the University of Minnesota, College of Pharmacy. He also completed an Ambulatory Care residency at Regions Hospital in St. Paul, MN.
Posts by Chris Peterson, PharmD: